Morgan Stanley Further Reduces Sihuan Pharma Stake

Morgan Stanley Private Equity Asia (MSPEA) is continuing to lighten its stake in Sihuan Pharmaceutical. The US investment bank will sell 120 million shares of the China pharma for about $147 million. The investment has yielded spectacular returns for MSPEA, which bought 10% of Sihuan to help the company de-list from the Singapore exchange in 2009. The go-private transaction valued Sihuan at $458 million. It now has a market cap of $7.7 billion. More details.... Stock Symbol: (HK: 0460) Share this with colleagues: // //